Ετικέτες

Τετάρτη 7 Σεπτεμβρίου 2016

Scholar : Ειδοποίηση Μελετητή - [ ΣΤΟΜΑ

Ειδοποίηση Μελετητή:[ ΣΤΟΜΑΤΙΤΙΣ ]

Various toxicities: case report

B Sun - Reactions, 2016
... Various toxicities: case report A 44-year-old woman developed stomatitis, liver toxicity,
thrombocytopenia, leucopenia, fatigue, palpitation, decreased appetite, nausea, hypokalaemia,
hypocalcaemia, increased AST and ALP during treatment with everolimus [time to reactions ...
Google+ Facebook Twitter

Everolimus/exemestane

K Sakiyama - Reactions, 2016
... Grade 3 stomatitis, diarrhoea, anaemia and interstitial pneumonia: case report An 80-year-old
woman developed grade 3 stomatitis, diarrhoea, anaemia and interstitial pneumonia during
treatment with everolimus and exemestane [not all routes and dosages stated]. ...
Google+ Facebook Twitter

Impact of Comorbidity on Treatment Decision Making and Outcomes

JJ Lee, M Extermann - Cancer and Chronic Conditions, 2016
... The patients with GFR of 60 mL/min or less experienced more severe toxicities with cytopenia
(76 % vs. 61 %, OR = 1.86, p < 0.001), diarrhea (34 % vs. 29 %, OR = 3.76, p = 0.007), stomatitis
(10 % vs. 6 %, OR = 2.81, p = 0.002), and hand-foot syndrome (18 % vs. ...
Google+ Facebook Twitter

Biological Psychiatry of Cancer and Cancer Treatment

A Hodgkiss, HCLPA Hodgkiss - 2016
Page 1. X FIL&I) - = - II . - |0|0|0|CU Psychiatry of Concer and Concer º | Iregiment Andrew
Hodgkiss Page 2. Biological Psychiatry of Cancer and Cancer Treatment Page 3. Page
4. Biological Psychiatry of Cancer and Cancer Treatment ...
Google+ Facebook Twitter

[PDF] International Journal of Clinical & Experimental Dermatology

M Demirel, U Tursen, U Kavuzlu, TI Kaya, A Kokturk
... blood groups and Rh factor. The results were discussed with respect to literature.
The study group involved 100 patients of recurrent aphthous stomatitis. 42 of them
were female, 58 of them were male. Among 100 patients with ...
Google+ Facebook Twitter

MUTANT CHONDROITINASE ABC I COMPOSITIONS AND METHODS OF THEIR USE

B Kaur - US Patent 20,160,244,740, 2016
Disclosed are compositions comprising mutant chondroitinase ABC I and
methods of their use. Compositions comprising either the nucleic acid or amino
acid sequence of mutant chondroitinase ABC I are di.
Google+ Facebook Twitter


Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google

Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου